| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
1.945 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
1.945 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
1.945 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
1.945 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
1.945 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
1.945 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
1.945 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
1.945 |
Evidence |
|
| HCAP-G |
NCAPG, CAPG, NYMEL3: Condensin complex subunit 3 |
SMC4L1 |
SMC4, CAPC, SMC4L1: Structural maintenance of chromosomes protein 4 |
1.945 |
Evidence |
|
| HDAC2 |
HDAC2: Histone deacetylase 2 |
ING3 |
ING3, HSPC301: Inhibitor of growth protein 3 |
1.945 |
Evidence |
|
| WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
HIST1H2BH |
HIST1H2BH, H2BFJ: Histone H2B type 1-H |
1.945 |
Evidence |
|
| DHX37 |
DHX37, DDX37, KIAA1517: Probable ATP-dependent RNA helicase DHX37 |
THOC4 |
THOC4, ALY, BEF: THO complex subunit 4 |
1.945 |
Evidence |
|
| PPP3CA |
PPP3CA, CALNA, CNA: Serine/threonine-protein phosphatase 2B catalytic subunit al |
PPP3R2 |
PPP3R2, RP11-102M4.2-001, hCG_1790899: Protein phosphatase 3 |
1.945 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
PPP3R2 |
PPP3R2, RP11-102M4.2-001, hCG_1790899: Protein phosphatase 3 |
1.945 |
Evidence |
|
| PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
1.945 |
Evidence |
|
| SMC2L1 |
SMC2, CAPE, PRO0324, SMC2L1: Structural maintenance of chromosomes protein 2 |
HCAP-G |
NCAPG, CAPG, NYMEL3: Condensin complex subunit 3 |
1.945 |
Evidence |
|
| WDR39 |
CIAO1, WDR39: Protein CIAO1 |
POLE4 |
POLE4: DNA polymerase epsilon subunit 4 |
1.945 |
Evidence |
|
| TXNL2 |
GLRX3, PICOT, HUSSY-22, TXNL2: Glutaredoxin-3 |
TP53RK |
TP53RK, C20orf64, PRPK: TP53-regulating kinase |
1.945 |
Evidence |
O
|
| PES1 |
PES1: Pescadillo homolog 1 |
WDR5 |
WDR5, BIG3: WD repeat-containing protein 5 |
1.945 |
Evidence |
|
| RANBP5 |
|
HSPC064 |
WDSOF1, HSPC064: WD repeat and SOF domain-containing protein 1 |
1.945 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
1.942 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
1.942 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
1.942 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
1.942 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
1.942 |
Evidence |
|